A.Menarini Diagnostics Announces Agreement with Skyla Corporation in the area of Point of Care Testing
Created by d.mariotti@vargroup.it on 7/23/2020 5:18:30 PM

Florence-based A. Menarini Diagnostics, part of the Menarini Group, and Taiwan-based Skyla Corporation, part of the Lite-On group...

Hsinchu, Taiwan and Florence, Italy, July 24th, 2020

Florence-based A. Menarini Diagnostics, part of the Menarini Group, and Taiwan-based Skyla Corporation, part of the Lite-On group, announce today that they have entered into a supply and distribution agreement concerning the LINX EVO clinical chemistry analyzer and the LINX DUO multi-assay analyzer.

Under this agreement, Menarini will be the exclusive distributor for the instruments and manage all marketing, sales and support activities in territories throughout EMEA and LATAM.

With this important partnership, Menarini will expand its portfolio in the strategical segment of Point of Care diagnostics with state of the art technology.

The LINX EVO analyzer allows the rapid dosage of clinical chemistry items and electrolytes from a single whole blood sample, thus representing an excellent solution for decentralized lab testing. The LINX DUO analyzer measures C-Reactive Protein, Lipids and Glycated Hemoglobin directly from capillary samples using single-test cartridges, for quick and optimized treatment at the point of need.

“We are proud to have a reliable and dynamic new partner in the area of Point-of-care testing” said Fabio Piazzalunga, General Manager of A. Menarini Diagnostics. “This cooperation will give us the opportunity to support quick clinical decisions directly where they are needed, and to address the treatments for the patients in a timely manner”.

“We are very much delighted to collaborate with A. Menarini Diagnostics and strongly believe that POCT is the future, because it could serve our customers in a more efficient and faster way. We will continue to launch products which fit the best with market needs and requirements and expect to provide better service to customers together with A. Menarini Diagnostics.” said Danny Liao, Chairman and CEO of Skyla Corporation Hsinchu Science Park Branch.



A. Menarini Diagnostics belongs to the Menarini Pharmaceutical Group which was founded in 1886. Today it is present in 140 countries throughout the world, it counts more than 17,000 employees and has a 2019 turnover of € 3.793 billion.

A. Menarini Diagnostics, the human touch of technology, is fully committed to develop high tech diagnostics instruments and reagents to improve the quality of life of patients, providing healthcare professionals the best possible solutions to diagnostics needs. For further information, please visit www.menarinidiagnostics.com

A.Menarini Diagnostics S.r.l. Via dei Sette Santi, 3 Florence Italy

Skyla, established in year 2011, is the new brand company of Lite-On Group. Skyla focused on healthcare products industry and built up a professional cross-disciplinary R&D team by virtue of the accumulation of solid and excellent manufacturing experience and competitive advantages in IT industry of parent company, Lite-On Technology Corporation. Through constantly developing new products for fitting the best with market needs and requirement, and optimizing current products for providing reliable and stable quality products, Skyla also strives to become a leader in advanced healthcare business and a trusted brand in the biotechnology medical industry. For acquiring more information about Skyla, please visit www.skyla.com

Skyla Corporation 1F, No. 8, Dusing Road, Hsinchu Science Park, Hsinchu City 30096, Taiwan (R.O.C.)

Fo further informations, click here.